| Code | CSB-RA545009A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
STXBP1, also known as Munc18-1, plays an essential role in synaptic vesicle exocytosis by binding syntaxin-1 and regulating SNARE complex assembly. This protein is critical for neurotransmitter release and has gained significant research attention due to its association with early infantile epileptic encephalopathy and other neurodevelopmental disorders. Understanding STXBP1 expression and localization provides valuable insights into synaptic function and neurological disease mechanisms.
This recombinant monoclonal antibody, developed using rabbit host immunization against a synthetic peptide derived from human STXBP1, offers the reproducibility and consistency that demanding neuroscience research requires. As a sequence-defined recombinant clone, it eliminates the lot-to-lot variability inherent in traditional hybridoma-derived antibodies, ensuring your experimental conditions remain stable across long-term studies and collaborative projects.
Validation studies demonstrate robust performance across multiple applications. Immunohistochemistry testing in paraffin-embedded human brain tissue reveals clear detection of STXBP1, confirming utility for examining expression patterns in normal neural tissue. Additional IHC validation in human glioma samples extends its applicability to cancer research contexts where altered synaptic protein expression may contribute to tumor biology. Flow cytometry analysis using A431 cells shows distinct positive signal separation from isotype control, with cells fixed in formaldehyde and permeabilized with Triton X-100, providing a validated protocol for intracellular detection studies.
The antibody is supplied in a glycerol-containing buffer optimized for long-term storage stability. With validated protocols for immunohistochemistry and flow cytometry at working dilutions of 1:50-1:200, this antibody supports researchers investigating synaptic transmission, epilepsy pathogenesis, and the broader landscape of neurological disorders where STXBP1 dysfunction contributes to disease.
There are currently no reviews for this product.